A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD)

Antonina A Mikocka-Walus, Andrea L Gordon, Benjamin J Stewart, Jane M Andrews

Research output: Contribution to journalArticlepeer-review

Abstract

Studies with healthy volunteers have demonstrated that antidepressants can improve immunoregulatory activity and thus they may have a potential to positively impact the disease course in inflammatory bowel disease (IBD), a chronic and incurable condition. However, patients' views on the role of antidepressants in the management of their IBD are unknown. Thus, this study aimed to explore patients' experiences and opinions regarding the effect of antidepressants on IBD course before possibly undertaking future treatment trials with antidepressants.
Original languageEnglish
Article number93
Pages (from-to)93
JournalBmc gastroenterology
Volume12
DOIs
Publication statusPublished - 20 Jul 2012

Cite this